Within the aldosterone-mineralocorticoid receptor (Aldo-MR) pathway, which is one of the primary drivers of cardiac remodeling following myocardial infarction, miR-181a has been demonstrated to act as a cardioprotective regulatory molecule. Here, NR3C2 is linked to myocardial infarction.